Given the complexity of the tumor microenvironment and the important role of SHP2 in cancer cell signaling, it is necessary to study the effect of inhibiting SHP2 activity in both tumor and immune cells to gain a better understanding of its therapeutic potential. Here, PTPN11 is linked to cancer.